Skip to main content

Xponance, Inc.

SEC CIK
0001637541
Latest filing
Aug 10, 2026

CRL holding history

Charles River Laboratories International, Inc. in every 13F filed by Xponance, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRL overviewAll 13F holders of CRLFull Q2 2026 holdings

Shares (Q2 2026)
5,302
Value
$1.20M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of CRL by Xponance, Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20265,302$1.20M<0.1%−43−0.8%ReducedHolders
Q1 20265,345$922.0K<0.1%+1,191+28.7%AddedHolders
Q4 20254,154$828.6K<0.1%+323+8.4%AddedHolders
Q3 20253,831$599.4K<0.1%−507−11.7%ReducedHolders
Q2 20254,338$658.2K<0.1%−46−1.0%ReducedHolders
Q1 20254,384$659.9K<0.1%−2,634−37.5%ReducedHolders
Q4 20247,018$1.30M<0.1%−251−3.5%ReducedHolders
Q3 20247,269$1.43M<0.1%+226+3.2%AddedHolders
Q2 20247,043$1.45M<0.1%−130−1.8%ReducedHolders
Q1 20247,173$1.94M<0.1%+428+6.3%AddedHolders
Q4 20236,745$1.59M<0.1%−644−8.7%ReducedHolders
Q3 20237,389$1.45M<0.1%+335+4.7%AddedHolders
Q2 20237,054$1.48M<0.1%−4,811−40.5%ReducedHolders
Q1 202311,865$2.39M<0.1%+42+0.4%AddedHolders
Q4 202211,823$2.58M<0.1%+1,027+9.5%AddedHolders
Q3 202210,796$2.13M<0.1%+1,021+10.4%AddedHolders
Q2 20229,775$2.09M<0.1%+1,516+18.4%AddedHolders
Q1 20228,259$2.35M<0.1%+105+1.3%AddedHolders
Q4 20218,154$3.07M<0.1%+811+11.0%AddedHolders
Q3 20217,343$3.03M0.1%−184−2.4%ReducedHolders
Q2 20217,527$2.78M0.1%−2,229−22.8%ReducedHolders
Q1 20219,756$2.83M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.